Weed Symbols for Packaging Cannabis, THC, and Marijuana Products

(A) Manufacture date and source.

(B) The statement "SCHEDULE I CONTROLLED SUBSTANCE."

(C) The statement "KEEP OUT OF REACH OF CHILDREN AND ANIMALS" in bold print.

(D) The statement "FOR MEDICAL USE ONLY."

(E) The statement "THE INTOXICATING EFFECTS OF THIS PRODUCT MAY BE DELAYED BY UP TO TWO HOURS."

(F) The statement "THIS PRODUCT MAY IMPAIR THE ABILITY TO DRIVE OR OPERATE MACHINERY. PLEASE USE EXTREME CAUTION."

(G) For packages containing only dried flower, the net weight of medical cannabis in the package.

(H) A warning if nuts or other known allergens are used.

(I) List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoid content, the THC and other cannabinoid amount in milligrams per serving, servings per package, and the THC and other cannabinoid amount in milligrams for the package total.

(J) Clear indication, in bold type, that the product contains medical cannabis.

(K) Identification of the source and date of cultivation and manufacture.

(L) Any other requirement set by the bureau.

(M) Information associated with the unique identifier issued by the Department of Food and Agriculture pursuant to Section 11362.777 of the Health and Safety Code.

(b) Only generic food names may be used to describe edible medical cannabis products.

Additional Florida Cannabis Warning Details

e. Package the marijuana in compliance with the United States Poison Prevention Packaging Act of 1970, 15 U.S.C. ss. 1471 et seq.

f. Package the marijuana in a receptacle that has a firmly affixed and legible label stating the following information:

(1) The marijuana or low-THC cannabis meets the requirements of sub-subparagraph d.

(II) The name of the medical marijuana treatment center from which the marijuana originates.

(III) The batch number and harvest number from which the marijuana originates and the date dispensed.

(IV) The name of the physician who issued the physician certification.

(V) The name of the patient.

(VI) The product name, if applicable, and dosage form, including concentration of tetrahydrocannabinol and cannabidiol. The product name may not contain wording commonly associated with products marketed by or to children.

(VII) The recommended dose.

(VIII) A warning that it is illegal to transfer medical marijuana to another person.

(IX) A marijuana universal symbol developed by the department.

12. The medical marijuana treatment center shall include in each package a patient package insert with information on the specific product dispensed related to:

a. Clinical pharmacology.

b. Indications and use.

c. Dosage and administration.

d. Dosage forms and strengths.

e. Contraindications.

f. Warnings and precautions.

g. Adverse reactions.

13. In addition to the packaging and labeling requirements specified in subparagraphs 11. and 12., marijuana in a form for smoking must be packaged in a sealed receptacle with a legible and prominent warning to keep away from children and a warning that states marijuana smoke contains carcinogens and may negatively affect health. Such receptacles for marijuana in a form for smoking must be plain, opaque, and white without depictions of the product or images other than the medical marijuana treatment center's department-approved logo and the marijuana universal symbol.

14. The department shall adopt rules to regulate the types, appearance, and labeling of marijuana delivery devices dispensed from a medical marijuana treatment center. The rules must require marijuana delivery devices to have an appearance consistent with medical
use.

15. Each edible shall be individually sealed in plain, opaque wrapping marked only with the marijuana universal symbol. Where practical, each edible shall be marked with the marijuana universal symbol. In addition to the packaging and labeling requirements in subparagraphs 11. and 12., edible receptacles must be plain, opaque, and white without depictions of the product or images other than the medical marijuana treatment center's department-approved logo and the marijuana universal symbol. The receptacle must also include a list of all the edible's ingredients, storage instructions, an expiration date, a legible and prominent warning to keep away from children and pets, and a warning that the edible has not been produced or inspected pursuant to federal food safety laws.

“Cannabis-infused products (other than those intended for topical application) must contain a statement "CAUTION: This product contains cannabis, and intoxication following use may be delayed 2 or more hours. This product was produced in a facility that cultivates cannabis, and that may also process common food allergens.”

“Cannabis-infused products intended for topical application must contain a statement "DO NOT EAT" in bold, capital letters.”

Link here

Additional Information

Maine’s cannabis labels on prepared marijuana and goods containing marijuana that are sold by dispensaries and caregivers are used as evidence of compliance with the law that limits possession and dispensing to 2.5 ounces of prepared marijuana per qualifying patient. The packaging and labeling of prepared marijuana and marijuana products for sale by registered dispensaries and caregivers must comply with applicable State labeling laws.

See 22 M.R.S.A. §2157.

Some additional information on Maryland Cannabis warnings.

Minimum Font Size: Any information printed on the package or label must be at least 1/16 of an inch high, which is equivalent to size 4.5 font.

Other Notes: Bear clear warnings that: ○ Products may be lawfully consumed only by the qualifying patient listed on the label.

It is illegal for any person to possess or consume the contents of the package other than the qualifying patient, and it is illegal to transfer the package or its contents to any person other than for a caregiver to transfer to a qualifying patient.

Bear the following statements: “Consumption of medical cannabis may impair your ability to drive a car or operate machinery. Please use extreme caution.”

“There may be health risks associated with cannabis use, especially during pregnancy or breastfeeding.”

“This package contains cannabis. Keep out of the reach of children and animals.”

Additional Massachusetts Information

Placement: On the retail packaging or labeling of every cannabis product

Other Notes: Visit Link 1 | Link 2

Additional Information

Additional Information

Required Size, and Colors for symbol:

Universal Montana State Marijuana Symbol sized at least .33 inches wide by .33 inches high.

For product packaging, there are some warnings that are required as well:

Must Include:

• “This product has been tested and meets the requirements of the state of Montana”
• “Keep out of reach of children and pets”
• “This product may be addictive”
• “This product may have intoxicating effects. Do not drive under the influence of marijuana.”

May be Required:

• If manufactured: list chemical or solvent used
• If heat is not required to administer or consume: do not include total THC or total potential psychoactive THC on facts panel

Montana Exit Bag Rules

Currently our understanding from speaking with customers is that Exit bags must be Child resistant and contain the following warnings.

WARNING: Consumption of marijuana may cause anxiety, agitation, paranoia, psychosis, and cannabinoid hyperemesis.

WARNING: Consumption of marijuana by pregnant women may result in fetal injury and low birth weight.

WARNING: Consumption of marijuana by nursing mothers may result in infant hyperactivity and poor cognitive function.

Additional Information

Additional Information

Act 241 SLH 2015 - Section 11. Advertising and packaging.

The department shall establish standards regarding the advertising and packaging of marijuana and manufactured marijuana products: provided that the standards, at a minimum, shall require the use of packaging that:

1. Is child-resistant and opaque so that the product cannot be seen from outside the packaging

2. Uses only black lettering on a white background with no pictures or graphics;

3. Is clearly labeled with the phrase "For medical use only":

4. Is clearly labeled with the phrase "Not for resale or transfer to another person";

4. Is clearly labeled with the phrase "Not for resale or transfer to another person";

5. Includes instructions for use and "use by date":

6. Contains information about the contents and potency of the product;

7. Includes the name of the production center where marijuana in the product was produced, including the batch number and date of packaging:

8. Includes a barcode generated by tracking software; and in the case of a manufactured marijuana product, a listing of the equivalent physical weight of the marijuana used to manufacture the amount of the product that is within the packaging, pursuant to section.

Additional Information

C. Packaging and labeling: a manufacturer applicant shall submit a description and sample of the opaque, child-resistant packaging of the concentrate or cannabis-derived product that the manufacturer shall utilize, including a label that shall contain:

(1) the name of the entity that produced the cannabis and the name of the manufacturer;

(2) a batch number or code;

(3) a production date or expiration date, including a "use by" or "freeze by" date for products capable of supporting the growth of infectious, toxigenic, or spoilage microorganisms;

(4) a description of the number of units of usable cannabis contained within the product;

(5) instructions for use;

(6) warnings for use;

(7) instructions for appropriate storage:

(8) approved laboratory analysis, including the results of strength and composition within ten percent (10%) of numbers shown on the package:

(9) the name of the strain, product facts, or a nutrition fact panel, and a statement that the product is for medical use by qualified patients, to be kept away from children, and not for resale; and

(10) the name of the department-approved testing facility or facilities used for ingredient testing, and the type(s) of testing conducted.

Additional New York Cannabis Warning Information

Additional Information

1. Processed, packaged, and labeled according to the U.S. Food and Drug Administration's Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements, 21 CFR Part 111; and

2. Labeled with:

a. The name and address of the pharmaceutical processor;

b. The brand name of the cannabidiol oil or THC-A oil product that was registered with the board pursuant to 18VAC110-20-285;

c. A unique serial number that matches the product with the pharmaceutical processor batch and lot number so as to facilitate any warnings or recalls the board or pharmaceutical processor deem appropriate;

d. The date of testing and packaging:

e. The expiration date;

f. The quantity of cannabidiol oil or THC-A oil contained in the batch;

g. A terpenes profile and a list of all active ingredients, including:

(1) Tetrahydrocannabinol (THC);

(2) Tetrahydrocannabinol acid (THC-A);

(3) Cannabidiol (CBD):

(4) Cannabidiolic acid (CBDA); and

(5) Any other active ingredient that constitutes at least 1.0% of the batch used in the product; and

h. A pass or fail rating based on the laboratory's microbiological, mycotoxins, and heavy metals and pesticide